glp-1 receptor agonists for weight loss Top Balance Efficacy, Safety Comparing GLP-type therapies for weight

Breast Cancer Prevention The findings demonstrate that GLP-1 users had nearly 30% lower odds of being diagnosed with breast cancer

GLP-1 medications typically begin lowering blood glucose within 1-2 weeks of starting treatment, though optimal glycemic control usually requires 12-16 weeks as the dose is gradually increased

However, GLP1R agonists produce a variety of effects in the brain as well, making efforts to increase the ability of such drugs to cross the blood-brain barrier of high interest

Scott et al

Expected indication launch timelines for selected pipeline candidates Pharmaceutical companies are investing significantly in oral GLP-1s